Search

Author/Creator Oikawa, Tatsuo

1. Discovery of 1, 8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor. Issue 7 (1st April 2020)

Authors:
Yukawa, Takafumi; Nakahata, Takashi; Okamoto, Rei; Ishichi, Yuji; Miyamoto, Yasufumi; Nishimura, Satoshi; Oikawa, Tatsuo; Kubo, Kazuki; Adachi, Ryutaro; Satomi, Yoshinori; Nakakariya, Masanori; Amano, Nobuyuki; Kamaura, Masahiro; Matsunaga, Nobuyuki
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 28:Issue 7(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phenotypic Drug Screening for Dysferlinopathy Using Patient-Derived Induced Pluripotent Stem Cells. (28th June 2019)

Authors:
Kokubu, Yuko; Nagino, Tomoko; Sasa, Katsunori; Oikawa, Tatsuo; Miyake, Katsuya; Kume, Akiko; Fukuda, Mikiko; Fuse, Hiromitsu; Tozawa, Ryuichi; Sakurai, Hidetoshi
Journal:
Stem cells translational medicine
Issue:
Volume 8:Number 10(2019)
Page Start:
1017
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phenotypic Drug Screening for Dysferlinopathy Using Patient‐Derived Induced Pluripotent Stem Cells. (28th June 2019)

Authors:
Kokubu, Yuko; Nagino, Tomoko; Sasa, Katsunori; Oikawa, Tatsuo; Miyake, Katsuya; Kume, Akiko; Fukuda, Mikiko; Fuse, Hiromitsu; Tozawa, Ryuichi; Sakurai, Hidetoshi
Journal:
Stem cells translational medicine
Issue:
Volume 8:Number 10(2019)
Page Start:
1017
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗